Zenas BioPharma, Inc. (ZBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 20M 40M 60M Q2 '24: 50M Q3 '24: 0 Q4 '24: 5M Q1 '25: 15M Q2 '25: 15M Q3 '25: 15M Q4 '25: 10M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-600M -400M -200M 0 200M 400M 600M Q2 '24: -56.4M Q3 '24: -133M Q4 '24: -163.9M Q1 '25: -173.6M Q2 '25: -189.1M Q3 '25: -200.7M Q4 '25: -383.1M Q1 '26: -423.1M Q2 '26: -475.6M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Net Income TTM

-600M -400M -200M 0 200M 400M 600M Q4 '23: -37.1M Q1 '24: -45.8M Q2 '24: -54.8M Q3 '24: -129M Q4 '24: -157M Q1 '25: -162.8M Q2 '25: -177M Q3 '25: -189.9M Q4 '25: -377.7M Q1 '26: -425.2M Q2 '26: -484.4M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-240M -160M -80M 0 80M 160M 240M Q3 '24: -96.5M Q4 '24: -119.7M Q1 '25: -137.6M Q2 '25: -148.4M Q3 '25: -158.5M Q4 '25: -172.3M Q1 '26: -210.5M Q2 '26: -226M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-240M -160M -80M 0 80M 160M 240M Q4 '24: -119.8M Q1 '25: -137.8M Q2 '25: -148.5M Q3 '25: -158.6M Q4 '25: -172.4M Q1 '26: -210.5M Q2 '26: -226M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q3 '23: 1.9M Q1 '24: 1.6M Q2 '24: 1.6M Q3 '24: 7.7M Q1 '25: 41.8M Q2 '25: 41.9M Q3 '25: 42.2M Q1 '26: 55.6M Q2 '26: 63.1M Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-75.00 -50.00 -25.00 0.00 25.00 50.00 75.00 Q3 '24: -63.18 Q4 '24: -11.89 Q1 '25: 5.20 Q2 '25: 28.18 Q3 '25: 31.98 Q4 '25: -8.44 Q1 '26: -9.10 Q2 '26: -9.62 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.